Below you will find information about ongoing clinical trials being conducted by EPC members
Contents |
PMAPS - Pancreatitis – Microbiome As Predictor of Severity
A prospective multicentre translational study
This trial is registered on clinicaltrials.gov: NCT04777812
Hypothesis: The orointestinal microbiome may be utilized as early biomarkers for the severity and course of AP
Kindly note that this trial has reached the required number of participating centers.
For general questions, please contact:
Principal investigator: Prof. Albrecht Neesse (albrecht.neesse@med.uni-goettingen.de)
Study coordinator: Dr. Christoph Ammer-Herrmenau (christoph.herrmenau@med.uni-goettingen.de)
DRACULA Trial
Invitation to participate in a new study: DRACULA
We all know how challenging the drainage therapy of necrotizing acute pancreatitis can be. Drainage and irrigation regimes seem to vary greatly between centres and literature confirms this impression. For this reason, your colleagues at the LMU Munich would like to investigate the current practice of drainage and irrigation therapy of necrotising pancreatitis in a multicentre retrospective study (DRACULA Trial).
More info on the trial and how to participate can be found here.
Balancing Women Biliary Pancreatitis (BORN Study)
The Hungarian Pancreas Study Group is continuing its international investigations and invites all researchers to participate in the following study: "Balancing Safety and Effectiveness: A Study on Cholecystectomy in Pregnant Women With Biliary Pancreatitis"
This study aims to systematically analyze the current international practices and consequences of the management of biliary acute pancreatitis in pregnant patients. If you would like to participate in this study, your patient data should be entered anonymously into an Excel file and uploaded to a password-protected website by May 15, 2023. Requests should be sent to Dr. Dorottya Tarján at dori.tarjan@gmail.com
On behalf of the study scientific committee,
Péter Hegyi, Alexandra Mikó, and Dorottya Tarjan